Home > Insider Trading > Filing (0001140361-13-046211)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197543	J Robert Coury	1500 Corporate Drive Canonsburg PA 15317	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-11	147,400	$41.61	935,054	No	4	S	Direct
Common Stock	Disposition	2013-12-11	2,065	$42.49	932,989	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,957	Indirect	By 401(k) Plan

Footnotes

This sale of common stock was executed pursuant to an amended 10b5-1 trading plan dated November 20, 2013.
Represents the weighted average price of the reporting person's disposition of 147,400 shares in transactions ranging from $41.32 to $42.29.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 4 to this Form 4.
Represents the weighted average price of the reporting person's disposition of 2,065 shares in transactions ranging from $42.34 to $42.67.